UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Production, purification and availability of 211 At: Near term steps towards global access

Nuclear medicine and biology, 2021-09, Vol.100-101, p.12

2021

Volltextzugriff (PDF)

Astatine-211: production and availability

Current radiopharmaceuticals, 2011-07, Vol.4 (3), p.177-185

2011

Volltextzugriff (PDF)

Astatine-211 labeled anti-HER2 5F7 single domain antibody fragment conjugates: radiolabeling and preliminary evaluation

Nuclear medicine and biology, 2018-01, Vol.56, p.10-20

2018

Volltextzugriff (PDF)

Copper signaling axis as a target for prostate cancer therapeutics

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (20), p.5819-5831

2014

Volltextzugriff (PDF)

Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy

Frontiers in pharmacology, 2020-03, Vol.11, p.170

2020

Volltextzugriff (PDF)

Production, purification and availability of 211At: Near term steps towards global access

Nuclear medicine and biology, 2021-09, Vol.100-101 (C), p.12-23

2021

Volltextzugriff (PDF)

Effective Treatment of Human Breast Carcinoma Xenografts with Single-Dose 211At-Labeled Anti-HER2 Single-Domain Antibody Fragment

The Journal of nuclear medicine (1978), 2023-01, Vol.64 (1), p.124-130

2023

Volltextzugriff (PDF)

In situ growth of a PEG-like polymer from the C terminus of an intein fusion protein improves pharmacokinetics and tumor accumulation

Proceedings of the National Academy of Sciences - PNAS, 2010-09, Vol.107 (38), p.16432-16437

2010

Volltextzugriff (PDF)

Labeling a TCO-functionalized single domain antibody fragment with 18F via inverse electron demand Diels Alder cycloaddition using a fluoronicotinyl moiety-bearing tetrazine derivative

Bioorganic & medicinal chemistry, 2020-09, Vol.28 (17), p.115634-115634, Article 115634

2020

Volltextzugriff (PDF)

Stapled peptides as scaffolds for developing radiotracers for intracellular targets: Preliminary evaluation of a radioiodinated MDM2-binding stapled peptide in the SJSA-1 osteosarcoma model

Bioorganic & medicinal chemistry letters, 2022-06, Vol.66, p.128725-128725, Article 128725

2022

Volltextzugriff (PDF)

A Plasmonic Gold Nanostar Theranostic Probe for In Vivo Tumor Imaging and Photothermal Therapy

Theranostics, 2015-01, Vol.5 (9), p.946-960

2015

Volltextzugriff (PDF)

Site-Specific and Residualizing Linker for 18 F Labeling with Enhanced Renal Clearance: Application to an Anti-HER2 Single-Domain Antibody Fragment

Journal of Nuclear Medicine, 2021-11, Vol.62 (11), p.1624-1630

2021

Volltextzugriff (PDF)

Site-Specific and Residualizing Linker for 18F Labeling with Enhanced Renal Clearance: Application to an Anti-HER2 Single-Domain Antibody Fragment

The Journal of nuclear medicine (1978), 2021-11, Vol.62 (11), p.1624-1630

2021

Volltextzugriff (PDF)

Labeling Single Domain Antibody Fragments with Fluorine-18 Using 2,3,5,6-Tetrafluorophenyl 6‑[18F]Fluoronicotinate Resulting in High Tumor-to-Kidney Ratios

Molecular pharmaceutics, 2019-01, Vol.16 (1), p.214-226

2019

Volltextzugriff (PDF)

DNA Repair Inhibitors: Potential Targets and Partners for Targeted Radionuclide Therapy

Pharmaceutics, 2023-07, Vol.15 (7), p.1926

2023

Volltextzugriff (PDF)

Effective Treatment of Human Breast Carcinoma Xenografts with Single-Dose 211 At-Labeled Anti-HER2 Single-Domain Antibody Fragment

Journal of Nuclear Medicine, 2023-01, Vol.64 (1), p.124-130

2023

Volltextzugriff (PDF)

Fluorine-18 Labeling of the MDM2 Inhibitor RG7388 for PET Imaging: Chemistry and Preliminary Evaluation

Molecular pharmaceutics, 2021-10, Vol.18 (10), p.3871-3881

2021

Volltextzugriff (PDF)

Fluorine-18 labeling of an anti-HER2 VHH using a residualizing prosthetic group via a strain-promoted click reaction: Chemistry and preliminary evaluation

Bioorganic & medicinal chemistry, 2018-05, Vol.26 (8), p.1939-1949

2018

Volltextzugriff (PDF)

Preclinical Evaluation of 18F-Labeled Anti-HER2 Nanobody Conjugates for Imaging HER2 Receptor Expression by Immuno-PET

The Journal of nuclear medicine (1978), 2016-06, Vol.57 (6), p.967-973

2016

Volltextzugriff (PDF)

An Improved 211 At-Labeled Agent for PSMA-Targeted α-Therapy

Journal of Nuclear Medicine, 2022-02, Vol.63 (2), p.259-267

2022

Volltextzugriff (PDF)

Labeling single domain antibody fragments with 18F using a novel residualizing prosthetic agent — N-succinimidyl 3-(1-(2-(2-(2-(2-[18F]fluoroethoxy)ethoxy)ethoxy)ethyl)-1H-1,2,3-triazol-4-yl)-5-(guanidinomethyl)benzoate

Nuclear medicine and biology, 2021-09, Vol.100-101, p.24-35

2021

Volltextzugriff (PDF)

Site-specific radioiodination of an anti-HER2 single domain antibody fragment with a residualizing prosthetic agent

Nuclear medicine and biology, 2021-01, Vol.92, p.171-183

2021

Volltextzugriff (PDF)

Prostate-Specific Membrane Antigen-Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer

Journal of Nuclear Medicine, 2016-10, Vol.57 (Suppl 3), p.90S-96S

2016

Volltextzugriff (PDF)

(2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy

Journal of Nuclear Medicine, 2016-10, Vol.57 (10), p.1569-1575

2016

Volltextzugriff (PDF)

d-Amino Acid Peptide Residualizing Agents for Protein Radioiodination: Effect of Aspartate for Glutamate Substitution

Molecules (Basel, Switzerland), 2018-05, Vol.23 (5), p.1223

2018

Volltextzugriff (PDF)

1 – 25 von 422

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(397)
Mit Volltextzugriff
(399)

Publikationsform

Sprache

Englisch
(421)
Japanisch
(50)

Erscheinungsjahr

n.n

Thema

Science & Technology
(193)
Life Sciences & Biomedicine
(185)
Animals
(179)
Humans
(177)
Mice
(150)
Biological And Medical Sciences
(111)
Medical Sciences
(102)
Tissue Distribution
(100)
Radiology, Nuclear Medicine & Medical Imaging
(88)
Female
(76)
Mice, Inbred Balb C
(58)
Cell Line, Tumor
(56)
Pharmacology. Drug Treatments
(56)
Tumors
(56)
Mice, Nude
(52)
Oncology
(50)
Male
(49)
Iodine Radioisotopes
(45)
Chemistry
(39)
Physical Sciences
(39)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Production, purification and availability of 211 At: Near term steps towards global access

Astatine-211: production and availability

Astatine-211 labeled anti-HER2 5F7 single domain antibody fragment conjugates: radiolabeling and preliminary evaluation

Copper signaling axis as a target for prostate cancer therapeutics

Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy

Production, purification and availability of 211At: Near term steps towards global access

Effective Treatment of Human Breast Carcinoma Xenografts with Single-Dose 211At-Labeled Anti-HER2 Single-Domain Antibody Fragment

In situ growth of a PEG-like polymer from the C terminus of an intein fusion protein improves pharmacokinetics and tumor accumulation

Labeling a TCO-functionalized single domain antibody fragment with 18F via inverse electron demand Diels Alder cycloaddition using a fluoronicotinyl moiety-bearing tetrazine derivative

Stapled peptides as scaffolds for developing radiotracers for intracellular targets: Preliminary evaluation of a radioiodinated MDM2-binding stapled peptide in the SJSA-1 osteosarcoma model

A Plasmonic Gold Nanostar Theranostic Probe for In Vivo Tumor Imaging and Photothermal Therapy

Site-Specific and Residualizing Linker for 18 F Labeling with Enhanced Renal Clearance: Application to an Anti-HER2 Single-Domain Antibody Fragment

Site-Specific and Residualizing Linker for 18F Labeling with Enhanced Renal Clearance: Application to an Anti-HER2 Single-Domain Antibody Fragment

Labeling Single Domain Antibody Fragments with Fluorine-18 Using 2,3,5,6-Tetrafluorophenyl 6‑[18F]Fluoronicotinate Resulting in High Tumor-to-Kidney Ratios

DNA Repair Inhibitors: Potential Targets and Partners for Targeted Radionuclide Therapy

Effective Treatment of Human Breast Carcinoma Xenografts with Single-Dose 211 At-Labeled Anti-HER2 Single-Domain Antibody Fragment

Fluorine-18 Labeling of the MDM2 Inhibitor RG7388 for PET Imaging: Chemistry and Preliminary Evaluation

Fluorine-18 labeling of an anti-HER2 VHH using a residualizing prosthetic group via a strain-promoted click reaction: Chemistry and preliminary evaluation

Preclinical Evaluation of 18F-Labeled Anti-HER2 Nanobody Conjugates for Imaging HER2 Receptor Expression by Immuno-PET

An Improved 211 At-Labeled Agent for PSMA-Targeted α-Therapy

Labeling single domain antibody fragments with 18F using a novel residualizing prosthetic agent — N-succinimidyl 3-(1-(2-(2-(2-(2-[18F]fluoroethoxy)ethoxy)ethoxy)ethyl)-1H-1,2,3-triazol-4-yl)-5-(guanidinomethyl)benzoate

Site-specific radioiodination of an anti-HER2 single domain antibody fragment with a residualizing prosthetic agent

Prostate-Specific Membrane Antigen-Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer

(2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy

d-Amino Acid Peptide Residualizing Agents for Protein Radioiodination: Effect of Aspartate for Glutamate Substitution

Suchergebnisse filtern